Abbvie Inc. vs Natera, Inc.
ABBV vs NTRA — side-by-side comparison from reported financials. ABBV leads 5, NTRA leads 3 of 8 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Natera, Inc.
NTRA · Healthcare
$400.71+2.54%Strained
| Metric | ABBV | NTRA |
|---|---|---|
| Price | $276.43 | $400.71 |
| Market cap | $488B | $57.8B |
| Revenue (TTM) | $64.4B | $2.71B |
| Revenue growth | +1.8% | +41.1% |
| Net margin | 9.8% | -7.1% |
| Free cash flow | $18.2B | $84.2M |
| Net cash (debt) | ($56.2B) | $1.02B |
| 1-year price return | +19.8% | +131.6% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | — |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | -12% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 4 of 11 |
| Employees | 57,000 | 6,140 |
Full résumé-style profiles: ABBV CV · NTRA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.